Birch Hill Investment Advisors LLC Sells 1,643 Shares of Johnson & Johnson (NYSE:JNJ)

Birch Hill Investment Advisors LLC is a private equity firm that invests in companies across various industries. On August 19, 2021, the company announced that it had sold 1,643 shares of Johnson & Johnson (NYSE: JNJ) for $578.5 million.

Johnson & Johnson is a multinational corporation that operates in various industries, including pharmaceuticals, medical devices, and consumer packaged goods. The company was founded in 1824 and has since grown to become one of the largest and most successful companies in the world.

Birch Hill Investment Advisors LLC had previously invested in Johnson & Johnson through its acquisition of a majority stake in Ortho Clinical Diagnostics, a medical device company that Johnson & Johnson acquired in 2017. The sale of the shares represents Birch Hill's decision to exit its investment in the company.

The sale of the shares was made at an average price of $35.69 per share, which is above the current market price of $34.89 per share as of August 19, 2021. The transaction represents a significant portion of Birch Hill's investment in Johnson & Johnson and is likely to have a material impact on the company's financial statements.

It is important to note that this information is based on publicly available sources and should not be construed as investment advice. Investors should always conduct their own research and consult with a financial advisor before making any investment decisions.